HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo-controlled study in postmenopausal women

Authors

  • T. E. VOGELVANG,

    1. Project ‘Aging Women’ and the Institute for Cardiovascular Research-Vrije Universiteit (ICaR-VU), *Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, the Netherlands; †Department of Medical Biochemistry, University of Antwerp, Wilrijk, Belgium; for the HMR 3339 Research Group
    Search for more papers by this author
  • J. R. LEURS,

    1. Project ‘Aging Women’ and the Institute for Cardiovascular Research-Vrije Universiteit (ICaR-VU), *Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, the Netherlands; †Department of Medical Biochemistry, University of Antwerp, Wilrijk, Belgium; for the HMR 3339 Research Group
    Search for more papers by this author
  • V. MIJATOVIC,

    1. Project ‘Aging Women’ and the Institute for Cardiovascular Research-Vrije Universiteit (ICaR-VU), *Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, the Netherlands; †Department of Medical Biochemistry, University of Antwerp, Wilrijk, Belgium; for the HMR 3339 Research Group
    Search for more papers by this author
  • J. WILLEMSE,

    1. Project ‘Aging Women’ and the Institute for Cardiovascular Research-Vrije Universiteit (ICaR-VU), *Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, the Netherlands; †Department of Medical Biochemistry, University of Antwerp, Wilrijk, Belgium; for the HMR 3339 Research Group
    Search for more papers by this author
  • M. J. VAN DER MOOREN

    1. Project ‘Aging Women’ and the Institute for Cardiovascular Research-Vrije Universiteit (ICaR-VU), *Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, the Netherlands; †Department of Medical Biochemistry, University of Antwerp, Wilrijk, Belgium; for the HMR 3339 Research Group
    Search for more papers by this author

M. J. van der Mooren MD, PhD, Department of Obstetrics and Gynecology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, the Netherlands.
Tel: +31 (0) 20 4443244; fax: +31 (0) 20 4444422; e-mail: mj.vandermooren@VUmc.nl

No abstract is available for this article.

Ancillary